Clinical Study to Evaluate the Efficacy and Safety od BZ371B in Patients With Acute Respiratory Distress System (ARDS) in Mechanical Ventilation, Due to Respiratory Infections
Latest Information Update: 05 Jun 2023
At a glance
- Drugs BZ 371B (Primary)
- Indications Adult respiratory distress syndrome; COVID-19 pneumonia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Biozeus
- 05 Jun 2023 Status changed from recruiting to discontinued.
- 05 Aug 2022 Planned End Date changed from 1 Jun 2023 to 1 Nov 2023.
- 05 Aug 2022 Planned primary completion date changed from 1 Nov 2022 to 1 Nov 2023.